Search Results

Statins, fibrates, nicotinic acid, cholesterol absorption inhibitors, anion-exchange resins, omega-3 fatty acids: which drugs for which patients?

Author: Drexel, Heinz

Source: Fundamental & Clinical Pharmacology, Volume 23, Number 6, December 2009 , pp. 687-692(6)

Publisher: Blackwell Publishing

Synthesis and Bioactivities of 2-Azetidinones as Cholesterol Absorption Inhibitors

Authors: Ji, Jianfeng; Zhao, Rui; Huang, Wenlong; Zhang, Huibin; Zhou, Jinpei; Wang, Yubin; Qian, Hai

Source: Letters in Drug Design & Discovery, Volume 6, Number 6, September 2009 , pp. 424-427(4)

Publisher: Bentham Science Publishers

Cardiovascular risk prevention - room for improvement?

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 574, 2009-03-21 , pp. 3-3(1)

Publisher: Adis International

Ezetimibe cost-effective option in statin intolerance

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 571, 2009-02-07 , pp. 3-3(1)

Publisher: Adis International

Lack of Pharmacokinetic Interaction of Mipomersen Sodium (ISIS 301012), a 2′-O-Methoxyethyl Modified Antisense Oligonucleotide Targeting Apolipoprotein B-100 Messenger RNA, with Simvastatin and Ezetimibe

Authors: Yu, Rosie Z.; Geary, Richard S.; Flaim, JoAnn D.; Riley, Gina C.; Tribble, Diane L.; vanVliet, André A.; Wedel, Mark K.

Source: Clinical Pharmacokinetics, Volume 48, Number 1, 2009 , pp. 39-50(12)

Publisher: Adis International

Cost Effectiveness of Ezetimibe in Patients with Cardiovascular Disease and Statin Intolerance or Contraindications: A Markov Model

Authors: Ara, Roberta; Pandor, Abdullah; Tumur, Indra; Paisley, Suzy; Duenas, Alejandra; Williams, Robert; Rees, Angie; Wilkinson, Anna; Durrington, Paul; Chilcott, Jim

Source: American Journal of Cardiovascular Drugs, Volume 8, Number 6, 2008 , pp. 419-427(9)

Publisher: Adis International

Current and Future Pharmacologic Options for the Management of Patients Unable to Achieve Low-Density Lipoprotein-Cholesterol Goals with Statins

Authors: Karim El Harchaoui,; Akdim, Fatima; Stroes, Erik S.G.; Trip, Mieke D.; Kastelein, John J.P.

Source: American Journal of Cardiovascular Drugs, Volume 8, Number 4, 2008 , pp. 233-242(10)

Publisher: Adis International

Combination Therapy of Statins with Ezetimibe

Authors: Moriguchi, Emilio H.; Vieira, Jose Luiz d.C.

Source: Immunology, Endocrine & Metabolic Agents - Medicinal Chemistry (Formerly, Volume 8, Number 2, June 2008 , pp. 189-190(2)

Publisher: Bentham Science Publishers

Larvicidal Activity of Sterol Carrier Protein-2 Inhibitor in Four Species of Mosquitoes

Authors: Larson, Ryan T.; Wessely, Vilena; Jiang, Zhisheng; Lan, Que

Source: Journal of Medical Entomology, Volume 45, Number 3, May 2008 , pp. 439-444(6)

Publisher: Entomological Society of America

Effects of ezetimibe, simvastatin, atorvastatin, and ezetimibe-statin therapies on non-cholesterol sterols in patients with primary hypercholesterolemia

Authors: Assmann, Gerd; Kannenberg, Frank; Ramey, Dena R.; Musliner, Thomas A.; Gutkin, Stephen W.; Veltri, Enrico P.

Source: Current Medical Research and Opinion, Volume 24, Number 1, January 2008 , pp. 249-259(11)

Publisher: Informa Healthcare

Human cholesterol metabolism and therapeutic molecules

Authors: Charlton-Menys, V.; Durrington, P. N.

Source: Experimental Physiology, Volume 93, Number 1, January 2008 , pp. 27-42(16)

Publisher: Blackwell Publishing

Pharmacological Regulation of Dyslipoproteinaemia in Insulin Resistant States

Authors: Watts, Gerald F.; Chan, Dick C.

Source: Current Vascular Pharmacology, Volume 6, Number 1, January 2008 , pp. 67-77(11)

Publisher: Bentham Science Publishers

Design and Synthesis of 2-Azetidinone Cholesterol Absorption Inhibitors

Authors: Zhang, Huibin; Wang, Yubin; Zhao, Rui; Huang, Wenlong; Li, Yunman; Zhou, Jinpei

Source: Letters in Drug Design & Discovery, Volume 5, Number 1, January 2008 , pp. 39-42(4)

Publisher: Bentham Science Publishers

Cholesterol absorption inhibitors in the treatment of hyperlipidemia: clinical outcomes in large clinical trials

Author: Kesäniemi, Antero

Source: Fundamental & Clinical Pharmacology, Volume 21, Supplement 2, November 2007 , pp. 29-30(2)

Publisher: Blackwell Publishing

New azetidinone cholesterol absorption inhibitors

Author: Bai, Xu

Source: Expert Opinion on Therapeutic Patents, Volume 17, Number 7, July 2007 , pp. 791-797(7)

Publisher: Informa Healthcare

Bioactives for cholesterol lowering: targeting of cholesterol absorption pathways

Authors: Leifert, Wayne R; Abeywardena, Mahinda Y

Source: Expert Opinion on Drug Discovery, Volume 2, Number 5, May 2007 , pp. 597-602(6)

Publisher: Informa Healthcare

Ezetimibe: an update on the mechanism of action, pharmacokinetics and recent clinical trials

Authors: Sweeney, Mary Ellen; Johnson, Rebecca R

Source: Expert Opinion on Drug Metabolism and Toxicology, Volume 3, Number 3, June 2007 , pp. 441-450(10)

Publisher: Informa Healthcare

Effectiveness and Safety of Ezetimibe Added to Statin Therapy in Patients with Primary Dyslipidaemia not Achieving the LDL-C Treatment Goal on Statin Monotherapy

Authors: González, Carlos A.; Rubio-Guerra, Alberto F.; Pavía, Abel; Redding, Francisco J.; Cervantes, José L.; Zacarías, José L.; Yza, Rubén; Carranza, Jaime; Fernández, Pedro; Morales, Enrique; Robles, Francisco J.; Leyva, José L.; Rodríguez, Leticia

Source: Clinical Drug Investigation, Volume 27, Number 5, 2007 , pp. 333-337(5)

Publisher: Adis International

Many patients with DM missing lipid targets, missing treatment

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 525, 2007-04-07 , pp. 7-7(1)

Publisher: Adis International

MTP inhibition as a treatment for dyslipidaemias: time to deliver or empty promises?

Authors: Burnett, John R; Watts, Gerald F

Source: Expert Opinion on Therapeutic Targets, Volume 11, Number 2, February 2007 , pp. 181-189(9)

Publisher: Informa Healthcare